Sriram Ryali
Director of Finance/CFO bij CODEXIS, INC.
Vermogen: 617 084 $ op 31-03-2024
Profiel
Sriram Ryali is currently the Chief Financial & Accounting Officer at Codexis, Inc. Prior to his current position, he held various roles including Senior Director-Financial Planning & Analysis at Jazz Pharmaceuticals Plc, Vice President-Finance at Aimmune Therapeutics, Inc., Chief Financial Officer at Eiger BioPharmaceuticals, Inc., and Head-Medical Affairs, Technical Operations, R&D at Onyx Pharmaceuticals, Inc. Mr. Ryali completed his undergraduate degree at the University of California, Los Angeles and holds an MBA from UCLA Anderson School of Management.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
CODEXIS, INC.
0.25% | 01-01-2024 | 175 791 ( 0.25% ) | 613 511 $ | 31-03-2024 |
| 20-11-2023 | 714 ( 0.05% ) | 3 574 $ | 31-03-2024 |
Actieve functies van Sriram Ryali
| Bedrijven | Functie | Begin |
|---|---|---|
| CODEXIS, INC. | Director of Finance/CFO | 23-01-2023 |
Eerdere bekende functies van Sriram Ryali
| Bedrijven | Functie | Einde |
|---|---|---|
| EIGER BIOPHARMACEUTICALS, INC. | Director of Finance/CFO | 20-01-2023 |
| AIMMUNE THERAPEUTICS, INC. | Corporate Officer/Principal | 01-12-2018 |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Chief Tech/Sci/R&D Officer | 01-01-2015 |
| JAZZ PHARMACEUTICALS PLC | Corporate Officer/Principal | - |
Opleiding van Sriram Ryali
| University of California, Los Angeles | Undergraduate Degree |
| UCLA Anderson School of Management | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| CODEXIS, INC. | Process Industries |
| JAZZ PHARMACEUTICALS PLC | Health Technology |
| EIGER BIOPHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
Aimmune Therapeutics, Inc.
 Aimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aimmune Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of desensitization treatments for peanut and other food allergies. Its portfolio includes the characterized oral desensitization immunotherapy system. The firm product include Palforzia, which is an oral immunotherapy indicated for the mitigation of allergic reactions, including anaphylaxis that may occur with accidental exposure to peanut. The company was founded on June 24, 2011 and is headquartered in Brisbane, CA. | Health Technology |
